Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Corvus Pharmaceuticals (CRVS) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Soquelitinib, Cpi-818Hidradenitis Suppurativa (Hs)Phase IRecruitingSafety and Efficacy of Soquelitinib in Adults With Hidradenitis SuppurativaSep 03, 2026―
Soquelitinib, Cpi-818Atopic Dermatitis, Eczema, Eczema, Atopic, Atopic Dermatitis EczemaPhase IIRecruitingStudy to Evaluate Soquelitinib in Participants With Moderate to Severe ADFeb 23, 2026
Belinostat, Soquelitinib, PralatrexateLymphoma, T-Cell, Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-Cell Lymphoma, Follicular T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With Tfh Phenotype, Systemic Anaplastic Large Cell Lymphoma, Lymphoma, T-Cell, PeripheralPhase IIIRecruitingSoquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaAug 16, 2024
SoquelitinibAtopic DermatitisPhase ICompletedSafety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe ADMar 12, 2024
Cpi-818T-Cell LymphomaPhase IActive Not RecruitingA Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell LymphomaMay 07, 2019―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Corvus Pharmaceuticals Inc. (CRVS) have in its pipeline
Corvus Pharmaceuticals CRVS is currently developing the following drugs: Soquelitinib, Cpi-818, Belinostat, Soquelitinib, Pralatrexate, Soquelitinib, Cpi-818. These drug candidates are in various stages of clinical development as the company works toward FDA approval.